Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.

@article{Mariette2011MalignanciesAW,
  title={Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.},
  author={Xavier Mariette and Marco Matucci-Cerinic and Karel Pavelka and Peter B Taylor and Ronald F. van Vollenhoven and Rebecca Heatley and Claire E. Walsh and Richard Lawson and Alan Reynolds and P T J Emery},
  journal={Annals of the rheumatic diseases},
  year={2011},
  volume={70 11},
  pages={1895-904}
}
OBJECTIVES This project was undertaken to assess the risk of malignancy in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors (TNFi) in clinical practice, as recorded in prospective, observational studies. METHODS The authors undertook comprehensive searches of MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews and American College of Rheumatology, European League against Rheumatism and British Society for Rheumatology conference abstracts according to… CONTINUE READING